Advisory · Hematology
Gene therapy and cell therapy are reshaping deal structures.
Ambrosia provides senior-led advisory for hematology licensing, M&A, and strategic partnerships — backed by a proprietary database of 125 verified hematology transactions.
Deal Landscape
What hematology transactions actually look like.
Verified Transactions
125
Median Upfront
$72M
Key Structure Insight
Gene/cell therapy hematology deals use fundamentally different milestone structures
Stay Informed
Get new deal intelligence and transaction insights as we publish them.
No spam. Unsubscribe anytime.
Discuss your hematology transaction.
We’ll meet you at peer level — anywhere in the world.